MedPath

Tropicamide

Tropicamide Ophthalmic Solution, USP 1%Somerset Therapeutics, LLC

Approved
Approval ID

378b5fe2-4b5d-4c87-a7d6-fd0caa6402af

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 26, 2023

Manufacturers
FDA

Somerset Therapeutics, LLC

DUNS: 079947873

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tropicamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70069-121
Application NumberANDA207524
Product Classification
M
Marketing Category
C73584
G
Generic Name
Tropicamide
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateApril 26, 2023
FDA Product Classification

INGREDIENTS (7)

TROPICAMIDEActive
Quantity: 10 mg in 1 mL
Code: N0A3Z5XTC6
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 7/17/2021

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Container Label

Container Label

Carton Label

Carton Label

DESCRIPTION SECTION

LOINC: 34089-3Updated: 7/17/2021

DESCRIPTION

Tropicamide Ophthalmic Solution, USP is an anticholinergic prepared as a sterile topical ophthalmic solution. The active ingredient is represented by the chemical structure:

Image

Established name:

Tropicamide ophthalmic solution, USP

Chemical name:

Benzeneacetamide, N-ethyl-α-(hydroxymethyl)-N-(4-pyridinylmethyl).

**Each mL contains: Active:tropicamide 1%. Preservative:benzalkonium chloride 0.01%. Inactives:**sodium chloride, edetate disodium, hydrochloric acid and/or sodium hydroxide (to adjust pH), Water for injection. pH range 4.0

  • 5.8.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 10/24/2018

PRECAUTIONS

General

The lacrimal sac should be compressed by digital pressure for two to three minutes after instillation to reduce excessive systemic absorption.

Information for Patients

Do not touch dropper tip to any surface, as this may contaminate the solution. Patient should be advised not to drive or engage in potentially hazardous activities while pupils are dilated. Patient may experience sensitivity to light and should protect eyes in bright illumination during dilation. Parents should be warned not to get this preparation in their child's mouth and to wash their own hands and the child's hands following administration.

Drug Interactions

Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.

Carcinogenesis, Mutagenesis, Impairment of Fertility

There have been no long-term studies done using tropicamide in animals to evaluate carcinogenic potential.

Pregnancy

Animal reproduction studies have not been conducted with tropicamide. It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tropicamide should be given to a pregnant woman only if clearly needed.

Nursing Mothers

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when tropicamide is administered to a nursing woman.

Pediatric Use

Tropicamide may rarely cause CNS disturbances which may be dangerous in pediatric patients. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs (See WARNINGS). Keep this and all medications out of the reach of children.

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tropicamide - FDA Drug Approval Details